1
|
Yin GS, van der Heide F, Littlejohns TJ, Kuźma E, Hayat S, Brayne C, Foster PJ, Luben R, Khawaja AP. Association Between Retinal Nerve Fiber Layer Thickness and Incident Dementia in the European Prospective Investigation into Cancer in Norfolk Cohort. J Alzheimers Dis 2023; 95:691-702. [PMID: 37574729 DOI: 10.3233/jad-230073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/15/2023]
Abstract
BACKGROUND Retinal nerve fiber layer (RNFL) thickness may reflect cerebral status. OBJECTIVE This study assessed the relationship between RNFL thickness and incident all-cause dementia in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) Eye Study. METHODS Glaucoma detection with variable corneal compensation (GDx-VCC) and Heidelberg Retinal Tomograph II (HRT II) derived global mean RNFL thickness from dementia-free participants at baseline within the EPIC-Norfolk Eye Study were analyzed. Incident dementia was identified through linkage to electronic medical records. Cox proportional hazard mixed-effects regression models adjusted for key confounders were used to examine the associations between RNFL thickness and incident dementia in four separate models. RESULTS 6,239 participants were included with 322 cases of incident dementia and mean age of 67.5-years old, with 49.7% women (median follow-up 13.2-years, interquartile range (11.7 to 14.6 years). Greater RNFL thickness (GDx-VCC) was not significantly associated with a lower risk of incident dementia in the full adjusted model [HR per quartile increase 0.95; 95% CI 0.82-1.10]. Similarly, RNFL thickness assessed with HRT II was also not associated with incident dementia in any model (full adjusted model; HR per quartile increase: 1.06; [95% CI 0.93-1.19]. Gender did not modify any associations under study. CONCLUSION GDx-VCC and HRT II derived RNFL thickness are unlikely to be useful predictors of incident dementia. Higher resolution optical imaging technologies may clarify whether there are useful relationships between neuro-retinal morphology and brain measures.
Collapse
Affiliation(s)
- Grace S Yin
- Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, UK
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
| | - Frank van der Heide
- Cardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands
- Department of Internal Medicine, Maastricht University Medical Center, the Netherlands
| | | | - Elżbieta Kuźma
- Albertinen-Haus Centre for Geriatrics and Gerontology, University of Hamburg, Hamburg, Germany
| | - Shabina Hayat
- Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, England, UK
| | - Carol Brayne
- Cambridge Public Health, University of Cambridge, Cambridge, UK
| | - Paul J Foster
- NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK
| | - Robert Luben
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
- NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK
| | - Anthony P Khawaja
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
- NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK
| |
Collapse
|
2
|
Calvó-Perxas L, Belchí O, Turon-Estrada A, Van Eendenburg C, Linares M, Viñas M, Manzano A, Turró-Garriga O, Vilalta-Franch J, Garre-Olmo J. Incidence and characteristics of uncommon dementia subtypes: Results from 10 years of clinical surveillance by the Registry of Dementia of Girona. Alzheimers Dement 2019; 15:917-926. [PMID: 31175028 DOI: 10.1016/j.jalz.2019.03.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Revised: 03/18/2019] [Accepted: 03/25/2019] [Indexed: 10/26/2022]
Abstract
INTRODUCTION Age- and sex-stratified incidence rates of uncommon dementia subtypes are imprecise and scarce. METHODS We used data from 7357 newly diagnosed individuals aged between 30.6 and 101.0 years from the Registry of Dementia of Girona during 2007-2016 to determine the incidence rates of uncommon dementia subtypes stratified by sex and age groups and to describe their clinical characteristics. RESULTS Uncommon dementia subtypes were classified according to their etiology. The incidence rate of uncommon dementia subtypes was 27.8 cases per 100,000 person-years for those aged 30 years and older, 3.7 cases per 100,000 person-years for people aged less than 65 years, and 110.9 per 100,000 person-years for those aged 65 years and older. Age, sex, dementia severity, and medical comorbidities were different depending on the dementia subtype. DISCUSSION There are differences in the incidence rates and the demographic and clinical characteristics among uncommon dementia subtypes for age and sex groups.
Collapse
Affiliation(s)
- Laia Calvó-Perxas
- Girona Biomedical Research Institute [IDIBGI], Salt (Girona) Catalonia, Spain
| | - Olga Belchí
- Memory Clinic, Hospital de Palamós, Palamós, Catalonia, Spain
| | - Antoni Turon-Estrada
- Department of Neurology, Hospital Universitari Josep Trueta - Hospital Santa Caterina, Girona, Catalonia, Spain
| | | | - Marta Linares
- Neurology and Geriatrics Departments, Hospital d'Olot, Olot, Catalonia, Spain
| | - Marta Viñas
- Neurology and Geriatrics Departments, Hospital de Blanes, Blanes, Catalonia, Spain
| | - Anna Manzano
- Neurology and Geriatrics Departments, Hospital de Campdevànol, Campdevànol, Catalonia, Spain
| | - Oriol Turró-Garriga
- Girona Biomedical Research Institute [IDIBGI], Salt (Girona) Catalonia, Spain; Department of Neurology, Hospital Universitari Josep Trueta - Hospital Santa Caterina, Girona, Catalonia, Spain
| | - Joan Vilalta-Franch
- Girona Biomedical Research Institute [IDIBGI], Salt (Girona) Catalonia, Spain; Department of Neurology, Hospital Universitari Josep Trueta - Hospital Santa Caterina, Girona, Catalonia, Spain; University of Girona, Department of Medical Sciences, Girona, Catalonia, Spain
| | - Josep Garre-Olmo
- Girona Biomedical Research Institute [IDIBGI], Salt (Girona) Catalonia, Spain; Department of Neurology, Hospital Universitari Josep Trueta - Hospital Santa Caterina, Girona, Catalonia, Spain; University of Girona, Department of Medical Sciences, Girona, Catalonia, Spain.
| | | |
Collapse
|
3
|
Saifadini R, Tajadini H, Choopani R, Mehrabani M, Kamalinegad M, Haghdoost A. Perception of Alzheimer Disease in Iranian Traditional Medicine. IRANIAN RED CRESCENT MEDICAL JOURNAL 2016; 18:e22054. [PMID: 27247784 PMCID: PMC4884442 DOI: 10.5812/ircmj.22054] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 07/14/2014] [Revised: 10/20/2014] [Accepted: 12/08/2014] [Indexed: 11/18/2022]
Abstract
Context: Alzheimer disease (AD) is the most common cause of dementia. In regards to the world’s aging population, control and treatment of AD will be one of the major concerns of global public health in the next century. Alzheimer disease was not mentioned with the same phrase or its equivalent in traditional medical texts. The main of present paper was to investigate symptoms and causes of alzheimer disease from the view point of Iranian traditional medicine. Evidence Acquisition: In this qualitative study, we searched reliable sources of Iranian traditional medicine such as Canon of Medicide by Avicenna (Al-Quanon fi- tibb), Aghili cure by Aghili’s (Molajat-E-aghili), Tib-E-Akbari, Exire -E-Aazam and Sharh-E-Asbab and some reliable resources of neurology were probed base on keywords to find a disease that had the most overlap in terms of symptoms with alzheimer disease. By taking from the relevant materials, the extracted texts were compared and analyzed. Results: Findings showed that alzheimer disease has the most overlap with Nesyan (fisad-e-zekr, fisad-e-fekr and fisad-e-takhayol) symptoms in Iranian traditional medicine. Although this is not a perfect overlap and there are causes, including coldness and dryness of the brain or coldness and wetness that could also lead to alzheimer disease according to Iranian traditional medicine. Conclusions: According to Iranian traditional medicine, The brain dystemperement is considered the main causes of alzheimer disease. By correcting the brain dystemperement, alzheimer can be well managed. This study helps to suggest a better strategy for preventing and treating alzheimer in the future.
Collapse
Affiliation(s)
- Rostam Saifadini
- Neurology Research Center, Kerman University of Medical Sciences, Kerman, IR Iran
| | - Haleh Tajadini
- Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
- Corresponding Author: Haleh Tajadini, Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran. Tel: +98-2188776027, E-mail:
| | - Rasool Choopani
- Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
| | - Mitra Mehrabani
- Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, IR Iran
| | - Mohamad Kamalinegad
- School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
| | - Aliakbar Haghdoost
- Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, IR Iran
| |
Collapse
|
4
|
Analysis of Retinal Peripapillary Segmentation in Early Alzheimer's Disease Patients. BIOMED RESEARCH INTERNATIONAL 2015; 2015:636548. [PMID: 26557684 PMCID: PMC4628738 DOI: 10.1155/2015/636548] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 06/08/2015] [Indexed: 11/17/2022]
Abstract
Decreased thickness of the retinal nerve fiber layer (RNFL) may reflect retinal neuronal-ganglion cell death. A decrease in the RNFL has been demonstrated in Alzheimer's disease (AD) in addition to aging by optical coherence tomography (OCT). Twenty-three mild-AD patients and 28 age-matched control subjects with mean Mini-Mental State Examination 23.3 and 28.2, respectively, with no ocular disease or systemic disorders affecting vision, were considered for study. OCT peripapillary and macular segmentation thickness were examined in the right eye of each patient. Compared to controls, eyes of patients with mild-AD patients showed no statistical difference in peripapillary RNFL thickness (P > 0.05); however, sectors 2, 3, 4, 8, 9, and 11 of the papilla showed thinning, while in sectors 1, 5, 6, 7, and 10 there was thickening. Total macular volume and RNFL thickness of the fovea in all four inner quadrants and in the outer temporal quadrants proved to be significantly decreased (P < 0.01). Despite the fact that peripapillary RNFL thickness did not statistically differ in comparison to control eyes, the increase in peripapillary thickness in our mild-AD patients could correspond to an early neurodegeneration stage and may entail the existence of an inflammatory process that could lead to progressive peripapillary fiber damage.
Collapse
|
5
|
Mitzner TL, McBride SE, Barg-Walkow LH, Rogers WA. Self-Management of Wellness and Illness in an Aging Population. ACTA ACUST UNITED AC 2013. [DOI: 10.1177/1557234x13492979] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In this chapter, we review the last 10 years of literature on self-management of illnesses (acute/episodic and chronic) and wellness (e.g., health promotion). We focus on health self-management in the context of an aging population, wherein middle-aged adults are more likely to be managing wellness activities and older adults are often managing both maintenance of health and chronic illnesses. The critical issues related to self-management of health are discussed, including those imposed by health care demands and those stemming from individual differences in general abilities (e.g., motor, perception, cognition) and socioemotional characteristics. The dynamic relationship between theory and practice is highlighted. Health care demands reflect the nature of the illness or wellness activity and include managing comorbidities, symptoms, and medications; engaging in health promotion activities (e.g., exercise, diet); the required use of health technologies; the need for health-related information; and coordination of the care network. Individual differences in motor, perceptual, and cognitive abilities, as well as in the severity and complexity of the illness and the consequent demands, also impact how a person self-manages health. Cognitive abilities, such as decision making, knowledge, literacy (i.e., general, health, and e-health literacy), and numeracy are particularly implicated in the process of managing one’s own health and are especially important in the context of an aging population; therefore we give these cognitive abilities special attention in this chapter. Socioemotional characteristics, and attitudes and beliefs about one’s health, impact an individual’s self-management of health as well, impacting his or her motivation and goal-setting behaviors. Moreover, we discuss literature on interventions that have been used to improve self-management of health, and we examine the potential for technology. We conclude with guidelines for technology design and instruction, and discuss emerging themes.
Collapse
|
6
|
Ozkan S, Adapinar DO, Elmaci NT, Arslantas D. Apraxia for differentiating Alzheimer's disease from subcortical vascular dementia and mild cognitive impairment. Neuropsychiatr Dis Treat 2013; 9:947-51. [PMID: 23882142 PMCID: PMC3709829 DOI: 10.2147/ndt.s47879] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Although ideomotor limb apraxia is considered to be a typical sign of cortical pathologies such as Alzheimer's disease (AD), it has been also reported in subcortical neurodegenerative diseases and vascular lesions. We aimed to investigate the difference between AD, subcortical vascular dementia (SVaD) and mild cognitive impairment (MCI) patients by means of ideomotor limb apraxia frequency and severity. Ninety-six AD, 72 SVaD, and 84 MCI patients were assessed with the mini-mental status examination (MMSe), clinical dementia rating (CDR) and the apraxia screening test of TULIA (AST). Apraxia was significantly more frequent in the AD patients (32.3%) than in both of the SVaD (16.7%) and MCI (4.8%) patients. The frequency of apraxia was also significantly higher in SVaD patients than in MCI patients. AD patients had significantly lower apraxia scores than both SVaD and MCI patients. In addition, a significant difference was found between SVaD and MCI patients in terms of apraxia scores. These results suggest that the widespread belief of the association between apraxia and cortical dementias is not exactly correct. The significant difference between both of the dementia groups and the MCI patients suggests that the absence of apraxia can be an indicator for MCI diagnosis.
Collapse
Affiliation(s)
- Serhat Ozkan
- Department of Neurology, Eskişehir Osmangazi University Medical Faculty, Eskisehir, Turkey
| | | | | | | |
Collapse
|
7
|
Grand JHG, Caspar S, MacDonald SWS. Clinical features and multidisciplinary approaches to dementia care. J Multidiscip Healthc 2011; 4:125-47. [PMID: 21655340 PMCID: PMC3104685 DOI: 10.2147/jmdh.s17773] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2011] [Indexed: 12/14/2022] Open
Abstract
Dementia is a clinical syndrome of widespread progressive deterioration of cognitive abilities and normal daily functioning. These cognitive and behavioral impairments pose considerable challenges to individuals with dementia, along with their family members and caregivers. Four primary dementia classifications have been defined according to clinical and research criteria: 1) Alzheimer's disease; 2) vascular dementias; 3) frontotemporal dementias; and 4) dementia with Lewy bodies/Parkinson's disease dementia. The cumulative efforts of multidisciplinary healthcare teams have advanced our understanding of dementia beyond basic descriptions, towards a more complete elucidation of risk factors, clinical symptoms, and neuropathological correlates. The characterization of disease subtypes has facilitated targeted management strategies, advanced treatments, and symptomatic care for individuals affected by dementia. This review briefly summarizes the current state of knowledge and directions of dementia research and clinical practice. We provide a description of the risk factors, clinical presentation, and differential diagnosis of dementia. A summary of multidisciplinary team approaches to dementia care is outlined, including management strategies for the treatment of cognitive impairments, functional deficits, and behavioral and psychological symptoms of dementia. The needs of individuals with dementia are extensive, often requiring care beyond traditional bounds of medical practice, including pharmacologic and non-pharmacologic management interventions. Finally, advanced research on the early prodromal phase of dementia is reviewed, with a focus on change-point models, trajectories of cognitive change, and threshold models of pathological burden. Future research goals are outlined, with a call to action for social policy initiatives that promote preventive lifestyle behaviors, and healthcare programs that will support the growing number of individuals affected by dementia.
Collapse
Affiliation(s)
- Jacob HG Grand
- Department of Psychology, University of Victoria, Victoria, BC, Canada
| | - Sienna Caspar
- Interdisciplinary Graduate Studies, University of British Columbia, Vancouver, BC, Canada
| | | |
Collapse
|
8
|
[Diagnostic procedures and frequency of dementia. A prospective study in the daily routine of a geriatric hospital (PAOLA study)]. Z Gerontol Geriatr 2009; 42:385-90. [PMID: 19629559 DOI: 10.1007/s00391-009-0043-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2008] [Accepted: 03/30/2009] [Indexed: 10/20/2022]
Abstract
All 1019 patients admitted to the department of geriatric medicine of a general hospital were screened during an 11-month period prospectively and consecutively for dementia. This investigation is part of a study for investigation of informal caregivers and their willingness for home caregiving of dementia patients (PAOLA study). In about half of the 1019 patients, there was a suspicion of dementia by a median age of 83 years. In 28.2% (n=287) of all cases, dementia was clinically diagnosed and in 60.9% (n=621) it could be clinically ruled out at the time of investigation. Underlying diseases which initially misled to dementia suspicion were in 26.8% (n=30) of these cases depression disorders, 13.4% (n=15) intracranial lesions including tumor and hemorrhage, 8.9% (n=10) other psychiatric diseases including substance abuse as well as disabilities in seeing and hearing. These differential diagnoses might be treatable in individual cases. This study could not clarify in 10.9% (n=111) of all cases whether dementia was present in a patient at the time studied. It was mainly limited due to multiple concomitant morbidities and reduced patient communication skills.We recommend that structured diagnostic procedures and treatments should be performed at specialized centers in order to avoid missing any treatable underlying diseases. In addition, the patients should be followed up at regular intervals.
Collapse
|
9
|
Seibyl JP. Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders. Semin Nucl Med 2008; 38:274-86. [PMID: 18514083 DOI: 10.1053/j.semnuclmed.2008.03.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Neuroimaging biomarkers in movement disorders during the past decade have served as diagnostic agents (Europe), tools for evaluation of novel therapeutics, and a powerful means for describing pathophysiology by revealing in vivo changes at different stages of disease and within the course of an individual patient's illness. As imaging with agents tracking dopaminergic function become more available, the next decade promises to enhance our clinical sophistication in the optimal use of dopaminergic imaging biomarkers for differential diagnosis, characterization of at-risk populations, guiding selection and management of appropriate treatments. The clinical role of these agents as clinical tools goes hand in hand with the development and availability of disease-modifying drugs, which carry the additional requirement for early and accurate diagnosis and improved clinical monitoring once treatment is initiated. Challenges remain in the ideal application of neuroimaging in the clinical algorithms for patient assessment and management. Further, the application of imaging to other targets, both monamineric and nonmonoaminergic, could serve a function beyond the important delineation of pathologic change occurring in patients with Parkinson's disease to suggest some role in improved phenotyping and classification of patients with Parkinson's disease presenting with different symptom clusters. New areas of focus based on the elucidation of mechanisms at the cellular and molecular level, including intense interest in alpha-synuclein and other protein inclusions in neurons and glia, have piqued interest in their in vivo assessment using scinitigraphic methods. Perhaps ultimately, treatment that is targeted to a better delineated pathophysiology-based characterization of movement disorder patients will emerge. The application of neuroimaging biomarkers to multiple ends in movement disorders provides an important model for the multiple roles diagnostic imaging agents can serve in neurodegenerative disorders; for diagnosis, for elaborating pathophysiology in patient populations, for developing new drugs, ultimately for improving clinical management.
Collapse
Affiliation(s)
- John P Seibyl
- Institute for Neurodegenerative Disorders, Molecular Neuroimaging, LLC, Yale University School of Medicine, New Haven, CT, USA.
| |
Collapse
|
10
|
|
11
|
Abstract
PURPOSE OF REVIEW This review describes a variety of neuropsychological dementia studies published between January 2004 and June 2005. In selecting articles for description in the present paper, our goal was not a comprehensive review of what is an enormous and growing literature, but rather to select and describe individual interesting studies from a sufficient range of dementia-related topics to permit illustration of some of the important questions for which a neuropsychological perspective aids in the understanding of dementias. RECENT FINDINGS Findings in the studies reviewed include a variety of different topics. Some of the themes include the following: (a) Alzheimer's disease is the most common cause of dementia, but a large body of research documents that there are important cognitive differences among various types of dementia, (b) the emerging research is also important in demonstrating the need for more sensitive clinical screening measures, (c) cognitive data are strongly predictive of functional decline, and (d) subtle declines in verbal learning appear to precede clinical Alzheimer's disease. SUMMARY Neuropsychological data are key to progress in understanding and developing more effective treatments for Alzheimer's disease and other dementia. For instance, efforts to identify early markers of dementia will be a key component to development of early intervention strategies.
Collapse
Affiliation(s)
- Gauri Nayak Savla
- Division of Geriatric Psychiatry, Department of Psychiatry, University of California, San Diego 92161, USA
| | | |
Collapse
|
12
|
Abstract
As the population ages, dental and other health care providers will be working with more older adults (and their family members) with changing cognitive status than ever before in history. The intent of this article is to review common cognitive changes in older adults that will undoubtedly be seen in dental practices. Knowledge of the common signs and symptoms of age-related cognitive changes provides a basis on which to identify individuals with undiagnosed cognitive,changes. This article reviews the relationship between cognitive function, aging, and dementia (specifically, mild cognitive impairment and Alzheimer's disease), the role of the dental team in recognizing these conditions, and issues related to obtaining in-formed consent from cognitively impaired patients.
Collapse
Affiliation(s)
- Janet A Yellowitz
- Department of Health Promotion and Policy, Baltimore College of Dental Surgery, University of Maryland, 666 West Baltimore Street, Room 3E02, Baltimore, MD 21201, USA.
| |
Collapse
|